trending Market Intelligence /marketintelligence/en/news-insights/trending/p-nh2IfH76lecOutBaIYyw2 content esgSubNav
In This List

Peregrine Pharmaceuticals secures extension to meet Nasdaq noncompliance

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Peregrine Pharmaceuticals secures extension to meet Nasdaq noncompliance

Nasdaq granted Peregrine Pharmaceuticals Inc. additional time to regain compliance with the $1 minimum bid price requirement.

The company has until July 21 to comply with the listing standard.

Peregrine Pharmaceuticals recently received stockholder approval for an up to 1-for-7 reverse stock split of its common stock. The company has until July 7 to implement the stock split to prove its compliance with the listing rule.